Pharma major Dr Reddy’s Laboratories has launched Lamotrigine extended-release Tablets in the US market.
It is indicated for the treatment of seizures. The tablets are a therapeutic equivalent generic version of Lamictal XR (lamotrigine) which had combined US sales of approximately $300.5 million for the most recent 12 months ended in April 2013, said a release quoting IMS Health.